295 related articles for article (PubMed ID: 22564513)
1. Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress.
Chen HL; Chen HL; Yuan RH; Wu SH; Chen YH; Chien CS; Chou SP; Wang R; Ling V; Chang MH
J Cell Mol Med; 2012 Nov; 16(11):2679-89. PubMed ID: 22564513
[TBL] [Abstract][Full Text] [Related]
2. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine.
Zollner G; Fickert P; Fuchsbichler A; Silbert D; Wagner M; Arbeiter S; Gonzalez FJ; Marschall HU; Zatloukal K; Denk H; Trauner M
J Hepatol; 2003 Oct; 39(4):480-8. PubMed ID: 12971955
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membrane in MDCK II cells.
Kagawa T; Orii R; Hirose S; Arase Y; Shiraishi K; Mizutani A; Tsukamoto H; Mine T
J Gastroenterol; 2014 May; 49(5):890-9. PubMed ID: 23722250
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.
Soroka CJ; Boyer JL
Mol Aspects Med; 2014 Jun; 37():3-14. PubMed ID: 23685087
[TBL] [Abstract][Full Text] [Related]
6. Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.
Hrycay E; Forrest D; Liu L; Wang R; Tai J; Deo A; Ling V; Bandiera S
Mol Cell Biochem; 2014 Apr; 389(1-2):119-32. PubMed ID: 24399466
[TBL] [Abstract][Full Text] [Related]
7. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
[TBL] [Abstract][Full Text] [Related]
8. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
Razori MV; Maidagan PM; Ciriaci N; Andermatten RB; Barosso IR; Martín PL; Basiglio CL; Sánchez Pozzi EJ; Ruiz ML; Roma MG
Biochem Pharmacol; 2019 Oct; 168():48-56. PubMed ID: 31202734
[TBL] [Abstract][Full Text] [Related]
9. Cholestatic effect of large bilirubin loads and cholestasis protection conferred by cholic acid co-infusion: a molecular and ultrastructural study.
Labori KJ; Arnkvaern K; Bjørnbeth BA; Press CM; Raeder MG
Scand J Gastroenterol; 2002 May; 37(5):585-96. PubMed ID: 12059062
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish abcb11b mutant reveals strategies to restore bile excretion impaired by bile salt export pump deficiency.
Ellis JL; Bove KE; Schuetz EG; Leino D; Valencia CA; Schuetz JD; Miethke A; Yin C
Hepatology; 2018 Apr; 67(4):1531-1545. PubMed ID: 29091294
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506
[TBL] [Abstract][Full Text] [Related]
12. Metabolic preconditioning protects BSEP/ABCB11
Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
[TBL] [Abstract][Full Text] [Related]
13. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
14. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
Kruglov EA; Gautam S; Guerra MT; Nathanson MH
Hepatology; 2011 Nov; 54(5):1790-9. PubMed ID: 21748767
[TBL] [Abstract][Full Text] [Related]
15. Bile salt export pump (BSEP/ABCB11): trafficking and sorting disturbances.
Hayashi H; Sugiyama Y
Curr Mol Pharmacol; 2013 Jul; 6(2):95-103. PubMed ID: 23876151
[TBL] [Abstract][Full Text] [Related]
16. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
Cheng Y; Woolf TF; Gan J; He K
Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
[TBL] [Abstract][Full Text] [Related]
17. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis.
Wang R; Salem M; Yousef IM; Tuchweber B; Lam P; Childs SJ; Helgason CD; Ackerley C; Phillips MJ; Ling V
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):2011-6. PubMed ID: 11172067
[TBL] [Abstract][Full Text] [Related]
18. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
19. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
20. Genetic cholestasis, causes and consequences for hepatobiliary transport.
Jansen PL; Sturm E
Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
